Arrowstreet Capital Limited Partnership lifted its position in HealthSouth Corporation (NYSE:HLS) by 27.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 244,565 shares of the company’s stock after purchasing an additional 52,989 shares during the quarter. Arrowstreet Capital Limited Partnership owned 0.25% of HealthSouth Corporation worth $11,837,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of HealthSouth Corporation by 4.6% in the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock worth $364,571,000 after purchasing an additional 328,081 shares during the last quarter. William Blair Investment Management LLC grew its holdings in shares of HealthSouth Corporation by 13.9% in the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after purchasing an additional 525,767 shares during the last quarter. State Street Corp grew its holdings in shares of HealthSouth Corporation by 7.5% in the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock worth $151,479,000 after purchasing an additional 219,306 shares during the last quarter. Voya Investment Management LLC grew its holdings in shares of HealthSouth Corporation by 4.4% in the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock worth $78,485,000 after purchasing an additional 68,486 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of HealthSouth Corporation by 1.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock worth $70,597,000 after purchasing an additional 23,480 shares during the last quarter. 93.05% of the stock is currently owned by institutional investors and hedge funds.
In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $42.55, for a total transaction of $962,693.75. Following the completion of the transaction, the chief executive officer now owns 283,134 shares of the company’s stock, valued at $12,047,351.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by insiders.
WARNING: This report was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.tickerreport.com/banking-finance/2957399/arrowstreet-capital-limited-partnership-has-11-84-million-stake-in-healthsouth-corporation-hls.html.
Several equities research analysts have recently weighed in on HLS shares. KeyCorp started coverage on shares of HealthSouth Corporation in a report on Thursday, June 15th. They issued a “sector weight” rating on the stock. ValuEngine lowered shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Zacks Investment Research lowered shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Tuesday, August 15th. BidaskClub raised shares of HealthSouth Corporation from a “sell” rating to a “hold” rating in a report on Saturday, June 17th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $53.00 target price on shares of HealthSouth Corporation in a report on Wednesday, July 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $50.38.
Shares of HealthSouth Corporation (HLS) traded down 0.55% during midday trading on Friday, reaching $45.16. 40,754 shares of the company’s stock were exchanged. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71. The company’s 50 day moving average is $45.14 and its 200-day moving average is $45.33. The stock has a market cap of $4.46 billion, a PE ratio of 16.46 and a beta of 0.58.
HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The firm had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The business’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.69 earnings per share. Equities analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. The ex-dividend date is Friday, September 29th. This represents a $1.00 annualized dividend and a yield of 2.20%. HealthSouth Corporation’s payout ratio is presently 36.76%.
HealthSouth Corporation Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.